COMPASS Pathways plc (CMPS) Financial Ratios
8 years of historical data (2018–2025) · Healthcare · Medical - Care Facilities
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↓
N/A
—
5yr avg: 2.15
30Y Low1.6·High8.7
ROE
↓
-565.3%
↑-265% vs avg
5yr avg: -154.8%
30Y Low-230%·High-30%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
CMPS Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
COMPASS Pathways plc currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.2B | $645M | $255M | $446M | $341M | $884M | $1.7B | — | — |
| Enterprise Value | $1.1B | $517M | $122M | $259M | $199M | $614M | $1.5B | — | — |
| P/E Ratio → | -4.07 | — | — | — | — | — | — | — | — |
| P/S Ratio | — | — | — | — | — | — | — | — | — |
| P/B Ratio | — | — | 1.65 | 1.98 | 1.88 | 3.11 | 8.71 | — | — |
| P/FCF | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
CMPS EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — |
CMPS Profitability
Margins and return-on-capital ratios measuring operating efficiency
A negative ROE of -565.3% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — | — | — | — | — |
| Operating Margin | — | — | — | — | — | — | — | — | — |
| Net Profit Margin | — | — | — | — | — | — | — | — | — |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROE | -565.3% | -565.3% | -81.5% | -58.2% | -39.3% | -29.8% | -59.3% | -230.2% | — |
| ROA | -135.8% | -135.8% | -63.4% | -50.1% | -36.7% | -28.4% | -51.6% | -66.7% | -50.1% |
| ROIC | — | — | -442.5% | -261.3% | -302.3% | -594.0% | -714.4% | -342.3% | — |
| ROCE | -251.8% | -251.8% | -81.7% | -62.5% | -47.2% | -34.5% | -50.5% | -128.1% | -50.9% |
CMPS Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $150M exceeds total debt of $21M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | 0.21 | 0.15 | 0.01 | 0.01 | — | 2.48 | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | — | -0.86 | -0.83 | -0.78 | -0.95 | -0.97 | -0.46 | — |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — |
| Interest Coverage | -63.28 | -63.28 | -33.28 | -52.40 | — | — | — | — | — |
Net cash position: cash ($150M) exceeds total debt ($21M)
CMPS Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.77x is below 1.0, meaning current liabilities exceed current assets. The current ratio has declined from 13.33x to 0.77x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.77 | 0.77 | 5.92 | 13.33 | 12.29 | 19.55 | 29.36 | 1.35 | 14.24 |
| Quick Ratio | 0.77 | 0.77 | 5.92 | 13.33 | 12.29 | 19.55 | 29.36 | 1.35 | 13.72 |
| Cash Ratio | 0.60 | 0.60 | 4.85 | 11.23 | 9.18 | 18.09 | 27.60 | 1.05 | 12.41 |
| Asset Turnover | — | — | — | — | — | — | — | — | — |
| Inventory Turnover | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — |
CMPS Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
COMPASS Pathways plc does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $94M | $67M | $51M | $42M | $40M | $36M | $22M | $6M |
Peer Comparison
Compare CMPS with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 CMPSYou | $1B | -4.1 | — | — | — | — | -565.3% | — | — |
 MNMD | $2B | -10.0 | — | — | — | — | -64.1% | -389.5% | — |
 ATAI | $1B | -1.4 | — | — | 75.3% | -2439.7% | -389.9% | -57.0% | — |
 CYBN | $304M | -13.7 | — | — | — | — | -42.8% | -115.8% | — |
 SAVA | $64M | -2.5 | — | — | — | — | -17.2% | -634.1% | — |
 ACAD | $4B | 9.4 | 25.7 | 35.2 | 91.7% | 9.8% | 39.9% | 10.0% | 0.4 |
 INVA | $2B | 6.8 | 6.8 | 8.5 | 72.3% | 38.5% | 29.1% | 14.2% | 1.3 |
 AXSM | $13B | -68.1 | — | — | 92.6% | -26.5% | -252.1% | -1906.7% | — |
 ALTO | $388M | 31.4 | 14.0 | 44.9 | 3.8% | 0.8% | 5.7% | 1.9% | 3.0 |
 JAZZ | $14B | -38.5 | 23.7 | 10.9 | 88.2% | 5.3% | -8.5% | 2.1% | 7.1 |
 ABBV | $383B | 91.4 | 15.8 | 21.5 | 70.2% | 32.8% | 6214.7% | 23.9% | 2.4 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 8 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
CMPS — Frequently Asked Questions
Quick answers to the most common questions about buying CMPS stock.
What is COMPASS Pathways plc's P/E ratio?
COMPASS Pathways plc's current P/E ratio is -4.1x. This places it at the 50th percentile of its historical range.
What is COMPASS Pathways plc's ROE?
COMPASS Pathways plc's return on equity (ROE) is -565.3%. The historical average is -83.1%.
Is CMPS stock overvalued?
Based on historical data, COMPASS Pathways plc is trading at a P/E of -4.1x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.